ArticleBMC palliative care2024

Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study).

Hanna Hirschinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.